Clene Inc.

CLNN Nasdaq SEC CIK 1822791
Follow Clene Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $56K +273.3% vs same quarter last year
Net income $3.9M +144.6% vs same quarter last year
EPS, diluted $0.05 +105.9% vs same quarter last year
Operating cash flow −$4.6M −15.7% vs same quarter last year
Revenue by quarter
$91K
$81K
$27K
$15K
$77K
$15K
$90K
$56K
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income8 fiscal years
  • Revenue
  • Net income
−$60M−$40M−$20M$0$20MFY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25$200K−$26.2M
FY24$342K−$39.4M
FY23$654K−$49.5M
FY22$473K−$29.9M
FY21$723K−$9.7M
FY20$206K−$19.3M
FY19-−$16.2M
FY18--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−15000%−10000%−5000%0%5000%FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2578.5%−11541.5%−13086.5%
FY2479.5%−9676.3%−11520.5%
FY2381.5%−6198.8%−7569.4%
FY2294.5%−10234.5%−6325.2%
FY2160%−6912.6%−1347.2%
FY20-−9812.6%−9357.8%
FY19---
FY18---
Free cash flowOperating cash flow minus capital expenditure
−$60M−$40M−$20M$0FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25−$18.6M
FY24−$21.3M
FY23−$30.5M
FY22−$44.2M
FY21−$36M
FY20−$19.3M
FY19−$13.5M
FY18-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Clene
  • Healthcare median
−15000%−10000%−5000%0%FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearCleneHealthcare median
FY25−13086.5%−30.6%
FY24−11520.5%−47%
FY23−7569.4%−58%
FY22−6325.2%−80.4%
FY21−1347.2%−71.8%
FY20−9357.8%−62.2%
FY19-−46.2%
FY18-−49.6%